RetiNext

The company will continue the development of a molecule to contrast Retinal pathologies based on excitotoxicity

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Milan, Metropolitan City of Milan, Italy
  • Currency EUR
  • Founded February 2016
  • Employees 3

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free